Cargando…
Antrodia cinnamomea is a potentially effective complementary medicine for adjuvant therapy against breast cancer with bone metastasis: A case report
RATIONALE: Palbociclib (PAL) is a first-in-class selective inhibitor of the cyclin-dependent kinases 4 (CDK4) and CDK6 and is indicated for the treatment of hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) in combination with fulv...
Autores principales: | Long, Huei, Hu, Chi-Tan, Prijatelj, Vesna, Weng, Ching-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337546/ https://www.ncbi.nlm.nih.gov/pubmed/32629666 http://dx.doi.org/10.1097/MD.0000000000020808 |
Ejemplares similares
-
Antrodia Cinnamomea Prolongs Survival in a Patient with Small Cell Lung Cancer
por: Long, Huei, et al.
Publicado: (2019) -
Protective Effects of Antrodia Cinnamomea Against Liver Injury
por: Liu, Yen-Wenn, et al.
Publicado: (2012) -
Optimization of Protoplast Preparation and Regeneration of a Medicinal Fungus Antrodia cinnamomea
por: Wu, Jyun-De, et al.
Publicado: (2019) -
Genotoxic, teratotoxic and oral toxic assessments of Antrodia cinnamomea health food product (Leader Deluxe Antrodia cinnamomea(®))
por: Lin, Chin-Chung, et al.
Publicado: (2015) -
Current evidence for the hepatoprotective activities of the medicinal mushroom Antrodia cinnamomea
por: Yue, Patrick Ying-Kit, et al.
Publicado: (2013)